Skip to main content

Two Ebola vaccine candidates to enter phase 2 trials in DRC next week, WHO says

Two Ebola vaccine candidates to enter phase 2 trials in DRC next week, WHO says
— Photo: Anadolu Agency

The World Health Organization says trials of two vaccines targeting the Bundibugyo Ebola virus are expected to start in Bunia on Nov. 26 or 27. The outbreak has surpassed 11,300 cases and 5,500 deaths.

ru

Preparing…

The summary was written by AI from this story's own text.

That did not work. Please try again a little later.

Two experimental vaccines developed specifically against the Bundibugyo Ebola virus are expected to enter phase 2 clinical trials next week in the Democratic Republic of the Congo, the World Health Organization (WHO) said Tuesday, according to Anadolu Agency.

Dr. Meg Doherty told a WHO news conference in Geneva that the candidates were approved last week to advance to phase 2 of the Tumani randomized controlled trial.

The first vaccine, “ChAdOx1”, was developed by Oxford University and the Serum Institute of India. The second was developed by “Moderna”.

Doherty said testing was expected to begin on Nov. 26 or 27 in Bunia, where the trial is being conducted.

The second phase will assess the vaccines’ safety and immunogenicity, or their ability to trigger an immune response. Candidates that meet the required criteria will advance to phase 3, where researchers will evaluate their effectiveness against a comparator.

Launched on Oct. 23, the Tumani trial is designed to accommodate additional vaccine candidates as they become available.

More than 140 participants have enrolled so far, with thousands expected to take part as researchers extend testing to additional sites and deploy mobile teams, according to the WHO expert.

WHO Director-General Tedros Adhanom Ghebreyesus highlighted progress in vaccine development amid the outbreak, saying the two candidates could begin testing as early as next week.

Tedros said the outbreak had surpassed 11,300 cases and 5,500 deaths, while between 400 and 500 new infections continued to be reported each week.

He warned that insecurity, attacks on health workers and delays in identifying infections continued to hinder efforts to contain the epidemic. He added that attacks also discouraged people from seeking care at Ebola treatment centres.

OMM Bot · Shall I show you today’s 5 most read stories?

Author

Editorial board

All their articles ›
Loading next story…